Kelley, Brian http://orcid.org/0000-0002-1205-1804
Article History
First Online: 21 April 2020
Competing interests
: The author is employed by Vir Biotechnology, which is developing monoclonal antibodies for the treatment of pandemic diseases, such as COVID-19 and influenza.
Free to read: This content has been made available to all.